NIH Grant Funds Cancer Prevention mRNA Vaccine Research

A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 millionĀ grantĀ from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA (mRNA) vaccines to deter cancer development in at-risk groups.